Know What You're Buying, On Day One.

Synthetica AI, Inc. is a Delaware corporation operating a cloud-hosted enterprise AI platform [9], currently party to a merger agreement with Apex Software Corporation [10] (closing targeted by June 30, 2026). This report reviews corporate formation and governance documents [25], capitalization records [27], financing documents [26], material contracts, intellectual property filings [21], litigation records [20], insurance policies [1], [2], [3], employment records [28], tax filings [33], and audited financial statements [6].

The following findings define the company’s current legal posture:

• Unresolvable capitalization uncertainty. Series A preferred shares appear as 0 [6], 4.5 million [8], or 15 million [7] outstanding across four sources, directly affecting every approval threshold for the merger.
• Critical documentation gaps. Bylaws, all Stock Purchase Agreements, the equity incentive plan, the stock ledger, the credit agreement, and stockholder consents for the February 2025 Series C financing [26] are among dozens of material documents not produced.
• Expired and at-risk contracts. The AWS enterprise agreement [17] expired December 2025. The JPMorgan Chase technology MSA [13] expired approximately February 2026. Three insurance policies expired February 15, 2026 with no evidence of renewal.
• Change-of-control consents. Four agreements require consent or notice for the merger [7]; none has been obtained [10].
• IP ownership gaps and active patent litigation. Two patents were filed before or days after incorporation without documented assignment [21], and NeuralPath Technologies has filed a patent suit in D. Del. [20] asserting a patent bearing the same number the company claims as its own.
• R&D tax credit discrepancies. The $4.8M credit on the filed return [33] is nearly double the $2.5M produced by the supporting Deloitte study [34].

The following table reconstructs key corporate, financing, and operational events. Events in bold present open diligence issues.

Dates reconstructed from [6], [7], [8], [10], [13], [17], [19], [23], [25], [27]

The cadence of issuances and the overlap between the August 2022 SAFE conversion mechanics [22] and the Series B pricing resolution [24] remain the most scrutinized sequence in the working group’s request list. The 409A re-valuation initiated in April 2025 [15] overlaps the November 2025 option grants at a $14.20 strike price [18], and no board consent has been produced reconciling the two valuations. The merger timeline further compresses the diligence window: closing is targeted for June 30, 2026, roughly five months from the signing date, with interim operating covenants and regulatory filings to complete.

Two material renewal items fall inside the diligence period and have no corresponding action item in the data room — the AWS Enterprise Agreement (expired December 2025) [17] and the JPMorgan Chase Technology MSA (expired February 2026) [13]. The board minutes from the February 15, 2026 meeting [10] reference neither renewal nor alternative supplier negotiations, a gap counsel should surface with management before signing.

Good standing. A Good Standing Certificate dated January 31, 2026 confirms good standing in Delaware with all franchise taxes current. [35] The company is qualified as a foreign corporation in California, New York, Texas, Washington, Massachusetts, Colorado, and Illinois. [7]

Delaware file number discrepancy. The Good Standing Certificate references File No. 4524987 [35], while the Disclosure Schedules and CEO Certificate both reference File No. 5412891. [7], [8]

Probable UK subsidiary. The audited financials are styled as “Consolidated” and disclose a London lease [6]. No subsidiary formation documents, intercompany agreements, or entity details appear in the reviewed documents.

Source: [25 (A&R Certificate of Incorporation)]

Anti-dilution conflict. The charter [25] provides broad-based weighted average anti-dilution for Series A and B, but Series B additionally carries full ratchet protection for down-rounds below $5.50/share. The IRA [26] describes only broad-based weighted average for all series. Under Delaware law, the charter controls.

The audited financials [6] disclose a London office lease assumed at the consolidated level, implying an active UK subsidiary. ETTL UK Ltd. was formed in November 2024 [6], yet no subsidiary formation documents, intercompany services agreement, or transfer-pricing memorandum have been produced in the data room [7]. The missing intercompany agreement is material for purposes of Section 482 compliance and for the pre-closing restructuring deliverable.

The bylaws [25] authorize a five-seat board composed of three investor-designated directors (Sequoia, Andreessen Horowitz, Tiger Global), the Chief Executive Officer, and one independent director. The independent seat has been vacant since July 2025 following the resignation of Michelle Park [8]; no replacement has been appointed. Section 4.4 of the Stockholders’ Agreement [27] requires the independent director to sit on the audit and compensation committees — both currently operating with three members in violation of the agreement.

Sources: [7], [27], [6]

Preferred Stock: material inconsistency. Three mutually inconsistent positions exist. The equity statement [6] shows zero preferred shares at the January 1, 2024 opening balance. Yet the funding history in the Disclosure Schedules [7] confirms 15,000,000 Series A shares were issued in November 2021.

Discrepant figures shown in bold. Majority threshold per Section 4.5 of [25].

The board-approved equity incentive plan [8] authorizes an option pool of 5,200,000 shares, of which 3,837,500 are issued and outstanding across 47 grant agreements. Weighted-average strike price is $4.12. The most recent 409A valuation [15], dated October 2025, sets fair market value at $11.40 per share — approximately 5% below the Series C price. Three option grants issued in November 2025 reference a $14.20 strike [18], indicating a board re-valuation not reflected in the 409A report on file.

The data room contains four SAFEs executed during the Series B interim period (September 2022 to April 2023), aggregate purchase price of $8,500,000 [22]. Three use the standard post-money valuation cap format; one (executed with Founders Circle) includes a full-ratchet anti-dilution provision inconsistent with the other three [24]. All four convert automatically upon the next Qualified Financing at the lower of the valuation cap or the Series D price, creating a material dilution overhang upon any future financing event.

Sources: [13], [17], [19], [7], [30], [6], [11], [12], [14]

Insurance covenant noncompliance. The JPMorgan MSA [13] requires $10M cyber liability, $5M CGL per occurrence, $5M E&O, and $5M D&O. Current cyber coverage is $5M [3] and CGL is $1M per occurrence / $2M aggregate [2], both below contractual requirements.

Credit agreement not produced. The Disclosure Schedules [7] reference a $20M revolving credit facility with Silicon Valley Bank. The credit agreement itself, any amendments, compliance certificates, and current draw amounts were not included in the data room [30].

Based on the FY2025 revenue schedule [6], top-three enterprise customers account for 54% of ARR. The largest customer — a Fortune 500 financial services firm [16] — represents 28% of ARR under a three-year MSA [16] expiring June 2026. The MSA contains a 90-day termination-for-convenience clause available to the counterparty, and no renewal has been documented [7].

Standard indemnification caps across enterprise agreements range from 1× to 3× trailing-twelve-month fees, except the Stanford University Exclusive License [11] which carries uncapped indemnification for third-party IP claims. Data Processing Agreements [14] with JPMorgan, Amazon, and three other enterprise customers include unlimited liability carve-outs for data-breach events — a deviation from the company's template MSA terms.